Denosumab reduces burden of giant-cell tumor of the bone, study suggests
Friday, September 21, 2012 - 12:00
in Health & Medicine
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study.